Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Michael E. Lidsky is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for complex hepatopancreatobiliary (HPB) and gastrointestinal malignancies. His major contributions center on defining and optimizing the learning curve for robotic pancreaticoduodenectomy, demonstrating that prior experience with laparoscopic approaches can facilitate safe adoption of robotic methods. Dr. Lidsky has also pioneered comparative studies on robotic versus open placement of hepatic artery infusion pumps (HAIP) for advanced liver tumors, providing critical evidence that robotic approaches can achieve comparable outcomes with reduced morbidity. His work on gastroenteropancreatic neuroendocrine carcinomas has further clarified how surgical approach impacts both short-term recovery and long-term oncologic outcomes. With his most cited paper accumulating 9 citations, Dr. Lidsky’s research is shaping modern surgical practice by systematically evaluating the safety, efficacy, and learning requirements of robotic HPB surgery. His investigations into HAIP placement represent particularly notable work, addressing a growing clinical need as more centers adopt regional chemotherapy for liver malignancies. Dr. Lidsky’s scholarship provides essential guidance for surgeons transitioning to robotic platforms and helps establish evidence-based standards for minimally invasive HPB oncology.